ArticleScientific reports2026
Exploring novel resistant sources for chilli leaf curl disease in Capsicum annuum L. germplasm for genetic enhancement.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chilli, as a vegetable and spice, is an important constituent of Indian food. The major constraint that hampers chilli production is Chilli leaf curl disease (ChiLCD). It often leads to heavy yield losses as a result of which the farmers do not prefer chilli cultivation. Therefore, the present investigation has been undertaken to screen and evaluate chilli germplasm conserved in National genebank of India and identify lines resistant to ChiLCD. We screened 500 chilli accessions for four consecutive years (2021-2024) to identify the resistant lines. In the 2021 screening, 16 accessions were found highly resistant, 40 resistant, 33 moderately susceptible, 23 susceptible, and 388 highly susceptible. Accessions showing symptoms of Chilli leaf curl disease in each season were discarded, whereas resistant accessions were retained for repeated screening. From the advanced screening and validation during 2022-2024, some promising accessions were identified as EC771555, IC643853, EC772795, EC787119, EC769427, and IC607252 which maintained low disease incidence (≤ 5% PDI) and severity score one. Another 28 accessions were found resistant to ChiLCD. Quantitative PCR also confirmed very low viral titres (0.1-0.3-fold) in resistance accessions. The identified promising accessions can be used as donors in chilli improvement programs to develop resilient varieties that express good yield and quality under high disease pressure, reducing reliance on chemical controls. They also offer genetic resources for studying resistance mechanisms and molecular markers development for sustainable agriculture which leads to reduced production costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.